Skip to main content
SpringerLink
Log in

Differential Detection of Deletion 22q11.2 Syndrome by Specialty and Indication

  • Original Article
  • Published:
Pediatric and Developmental Pathology

Abstract

This study identified cytogenetic abnormalities in a population screened for deletion 22q11.2 syndrome (D22S) by fluorescence in situ hybridization (FISH) and G-banding and correlated these abnormalities to referring specialty and submitted indications. Requests for the D22S FISH assay were retrospectively reviewed over a 29-month period in our institution. Positive test results for D22S FISH and other abnormalities found by other FISH assays and G-banding were correlated to submitting specialist and indication. Thirteen medical services ordered D22S FISH testing on 297 patients over 29 months. The detection rate for all cytogenetic aberrations was 9.4% (28 of 297) including 5.4% (16 of 297) for D22S detection by FISH and 2.7% (8 of 297) for detection of additional cytogenetic anomalies by G-banding cytogenetics. Sixty-six of 297 patients negative by D22S FISH and G-banding were screened using other FISH assays and 3 of 47 (6.4%) patients screened using subtelomeric probes were positive for deletion and 1 of 3 (33%) patients screened for Prader-Willi syndrome was positive for deletion. Pediatric geneticists requested 53.9% (160 of 297) of the tests, yielding 60.7% (17 of 28) of positive test results. Tetralogy of Fallot and developmental delay were the indications associated with the most positive test results. In our institution, pediatric geneticists identify the largest spectrum of indications with D22S and appear most aware of the association of developmental delay with D22S. Performing conventional cytogenetics and other FISH assays, in addition to FISH for D22S, is important because there is considerable overlap between D22S and the phenotype of several other syndromes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Similar content being viewed by others

References

  1. Wilson DI, Burn J, Scambler P, Goodship J. DiGeorge syndrome: part of CATCH 22. Genetics 1993;30:852–856

    CAS  Google Scholar 

  2. Morrow B, Goldberg R, Carlson C, Gupta RD, Sirotkin H, Collins J, Dunham I, O’Donnell H, Scambler P, Shprintzen R, Kucherlapati R. Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome. Am J Hum Genet 1995;56:1391–1403

    PubMed  CAS  Google Scholar 

  3. Carlson C, Sirotkin H, Pandita R, Goldberg R, McKie J, Wadey R, Patanjali SR, Weissman SM, Anyane-Yeboa K, Warburton D, Scambler P, Shprintzen R, Kucherlapati R, Morrow BE. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am J Hum Genet 1997;61:620–629

    PubMed  CAS  Google Scholar 

  4. Driscoll DA, Salvin J, Sellinger B, Budarf ML, McDonald-Mcginn DM, Zackai EH, Emanuel BS. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counseling and prenatal diagnosis. J Med Genet 1993;30:813–817

    PubMed  CAS  Google Scholar 

  5. Takao A, Matsuoka R, Momma K. Conotruncal anomaly face syndrome: chromosome 22q11 deletion. In: Imai Y, Momma K, eds. Proceeding of the Second World Congress of Pediatric Cardiology, Cardiac Surgery. Armonk, NY: Futura Publishing, 1998;4–10

    Google Scholar 

  6. Giannotti A, Digilio MC, Marino B, Mingarelli R, Dallapiccola B. Cayler cardiofacial syndrome and del 22q1: part of the CATCH22 phenotype. Am J Med Genet 1994;53:303–304

    Article  PubMed  CAS  Google Scholar 

  7. Rauch A, Hofbeck M, Bähring S, Leiopold G, Trautmann U, Singer H, Pfeiffer RA. Monozygotic twins concordant for Cayler syndrome. Am J Med Genet 1998;75:113–117

    Article  PubMed  CAS  Google Scholar 

  8. Bawle EV, Conard J, Van Dyke DL, Czarnecki P, Driscoll DA. Seven new cases of Cayler cardiofacial syndrome with chromosome 22q11.2 deletion, including a familial case. Am J Med Genet 1998;79:406–410

    Article  PubMed  CAS  Google Scholar 

  9. McDonald-McGinn DM, Driscoll DA, Bason L, Christensen K, Lynch D, Sullivan K, Canning D, Zavod W, Quinn N, Rome J, Paris Y, Weinberg P, Clark BJ III, Emanuel BS, Zackai EH. Autosomal dominant “Opitz” GBBB syndrome due to a 22q11.2 deletion. Am J Med Genet 1995;59:103–113

    Article  PubMed  CAS  Google Scholar 

  10. Jones KL. Smith’s Recognizable Patterns of Malformation, 5th ed. Philadelphia: WB Saunders, 1997;266–267:616–617

    Google Scholar 

  11. Emanuel BS, Budarf ML, Scambler PJ. The genetic basis of conotruncal cardiac defects: the chromosome 22q11.2 deletion. In: Harvey RP, Rosenthal N, eds. Heart Development. New York: Academic Press, 1999;463–478

    Google Scholar 

  12. Tobias ES, Morrison N, Whiteford ML, Tolmie JL. Towards earlier diagnosis of 22q11 deletions. Arch Dis Child 1999;81:513–514

    Article  PubMed  CAS  Google Scholar 

  13. Rauch A, Hofbeck M, Leipold G, Klinge J, Trautmann U, Kirsch M, Singer H, Pfeiffer RA. Incidence and significance of 22q11.2 hemizygosity in patients with interrupted aortic arch. Am J Med Genet 1998;78:322–331

    PubMed  CAS  Google Scholar 

  14. Goldmuntz E. Clark BJ, Mitchell LE, Jawad AF, Cuneo BF, Reed L, McDonald-McGinn D, Chien P, Feuer J, Zackai EH, Emanuel BS, Driscoll DA. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol 1998;32:492–498

    Article  PubMed  CAS  Google Scholar 

  15. Arinami T, Ohtsuki T, Takase K, Shimizu H, Yoshikawa T, Horigome H, Nakayama J, Toru M. Screening for 22q11 deletions in a schizophrenia population. Schizophr Res 2001;52:167–170

    Article  PubMed  CAS  Google Scholar 

  16. Murphy KC. Schizophrenia and velo-cardio-facial syndrome Lancet 2002;359:426–430

    Article  PubMed  Google Scholar 

  17. Ivanov D, Kirov G, Norton N, Williams HJ, Williams NM, Nikolov I, Tzwetkova R, Stambolova SM, Murphy KC, Toncheva D, Thapar A, O’Donovan MC, Owen MJ. Chromosome 22q11 deletions, velo-cardio-facial syndrome and early-onset psychosis. Br J Psychiatry 2003;183:409–413

    Article  PubMed  CAS  Google Scholar 

  18. Volpe P, Marasini M, Caruso G, Marzullo A, Buonadonna AL, Arciprete P, DiPaolo S, Volpe G, Gentile M. 22q11 deletions in fetuses with malformations of the outflow tracts or interruption of the aortic arch: impact of additional ultrasound signs. Prenat Diagn 2003;23:752–757

    Article  PubMed  Google Scholar 

  19. Barrea C, Yoo S, Chitayat D, Valsangiacomo E, Winsor E, Smallhorn JF, Hornberger LK. Assessment of the thymus at echocardiography in fetuses at risk for 22q11.2 deletion. Prenat Diagn 2003;23:9–15

    Article  PubMed  Google Scholar 

  20. Leana-Cox J, Pangkanon S, Eanet KR, Curtin MS, Wulfsberg EA. Familial DiGeorge/velocardiofacial syndrome with deletions of chromosome area 22q11.2: report of five families with a review of the literature. Am J Med Genet 1996;65:509–516

    Article  Google Scholar 

  21. Digilio MC, Angioni A, DeSantis M, Lombardo A, Giannotti A, Dallapiccola B, Marino B. Spectrum of clinical variability in familial deletion 22q11.2: from full manifestation to extremely mild clinical anomalies. Clin Genet 2003;63:308–313

    Article  PubMed  CAS  Google Scholar 

  22. Iascone MR, Vittorini S, Sacchelli M, Spadoni I, Simi P, Giusti S. Molecular characterization of 22q11 deletion in a three-generation family with maternal transmission. Am J Med Genet 2002;108:319–321

    Article  PubMed  Google Scholar 

  23. Smith A, St Heaps L, Robson L. Apparently unrelated cytogenetic abnormalities among 462 probands referred for the detection of del(22q) by FISH. Am J Med Genet 2002;113:346–350

    Article  PubMed  Google Scholar 

  24. Velagaleti GVN, Kumar A, Lockhart LH, Matalon R. Patent ductus arteriosus and microdeletion 22q11 in a patient with Klinefelter syndrome. Ann Genet 2000;43:105–107

    PubMed  CAS  Google Scholar 

  25. Maraschio P, Zuffardi O, Dalla Fior T, Tiepolo L. Immunodeficiency, centromeric heterochromatin instability of chromosomes 1, 9, and 16, and facial anomalies: the ICF syndrome. J Med Genet 1998;25:173–180

    Google Scholar 

  26. Black DN, Taber KH, Hurley RA. Metachromatic dystrophy: a model for the study of psychosis. J Neuropsychiatry Clin Neurosci 2003;15:289–293

    PubMed  Google Scholar 

  27. Derbent M, Saygili A, Yilmaz Z, Kervancioğlu M, Balci S, Tokel K. Co-occurrence of chromosome 22q11.2 microdeletion and trisomy 21 mosaicism. Am J Med Genet 2002;112:99–112

    PubMed  Google Scholar 

  28. Öskardttir S, Vujic M, Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child 2004;89:148–151

    Google Scholar 

  29. Crifasi PA, Michels VV, Driscoll DJ, Jalal SM, Dewald GW. DNA fluorescent probes for diagnosis of velocardiofacial and related syndromes. Mayo Clin Proc 1995;70:1148–1153

    Article  PubMed  CAS  Google Scholar 

  30. Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Seidel H, Schuffenhauer S, Oechsler H, Belohradsky B, Prieur M, Aurias A, Raymond FL, Clayton-Smith J, Hatchwell E, McKeown C, Beemer FA, Dallapiccola B, Novelli G, Hurst JA, Ignatius J, Green AJ, Winter RM, Brueton L, Brøndum-Nielsen K, Stewart F, Van Essen T, Patton M, Paterson J, Scambler PJ. Spectrum of clinical features associated with interstitial chromosome 22 q11 deletions: a European collaborative study. J Med Genet 1997;34:798–804

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank Leon A. Metlay, MD, and Chin-To Fong, MD, for a critical review of this report.

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Box 626, Rochester, New York, 14642, USA

    P. J. Katzman, B. Wang, M. Sawhney & N. Wang

Authors
  1. P. J. Katzman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Sawhney
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. J. Katzman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Katzman, P.J., Wang, B., Sawhney, M. et al. Differential Detection of Deletion 22q11.2 Syndrome by Specialty and Indication. Pediatr Dev Pathol 8, 557–567 (2005). https://doi.org/10.1007/s10024-005-0056-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10024-005-0056-1

Keywords

Search

Navigation